In adults with COVID-19 and severe hypoxemia, lower vs. higher oxygenation targets increased days alive without life support.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38950395.
- Also identified by DOI 10.7326/ANNALS-24-00558-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nielsen FM, Klitgaard TL, Siegemund M, et al; HOT-COVID Trial Group. <b>Lower vs higher oxygenation target and days alive without life support in COVID-19: the HOT-COVID randomized clinical trial.</b> JAMA. 2024;331:1185-1194. 38501214.
Medical subject headings
- COVID-19
- Hypoxia
- SARS-CoV-2